Rogaratinib

Manufactured by MedChemExpress

Rogaratinib is a selective inhibitor of the fibroblast growth factor receptor (FGFR) tyrosine kinases. It is designed to target specific mutations or amplifications in the FGFR gene, which have been associated with various types of cancer.

Automatically generated - may contain errors

Lab products found in correlation

Erdafitinib, by Selleck Chemicals (2 mentions) Infigratinib, by Selleck Chemicals (2 mentions) Futibatinib, by Selleck Chemicals (2 mentions) Derazantinib, by Selleck Chemicals (2 mentions) Zoligratinib, by Selleck Chemicals (2 mentions) Pemigatinib, by Selleck Chemicals (2 mentions) Ly2874455, by Selleck Chemicals (2 mentions) Azd4547, by Selleck Chemicals (2 mentions)

2 protocols using rogaratinib

Tyrosine Kinase Inhibitor Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols

Erdafitinib, infigratinib, pemigatinib, futibatinib, derazantinib, AZD4547, zoligratinib and LY2874455 were purchased from Selleck Chemicals. Rogaratinib was purchased from MedChemExpress.

, & Sibbald B. (2001). Global crusade to combat measles. CMAJ: Canadian Medical Association Journal, 164(11), 1609.

+ Open protocol

+ Expand

Small Molecule Kinase Inhibitor Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols

Erdafitinib, infigratinib, pemigatinib, futibatinib, derazantinib, AZD4547, zoligratinib, and LY2874455 were purchased from Selleck Chemicals. Rogaratinib was purchased from MedChemExpress.

Facchinetti F., Hollebecque A., Braye F., Vasseur D., Pradat Y., Bahleda R., Pobel C., Bigot L., Déas O., Florez Arango J.D., Guaitoli G., Mizuta H., Combarel D., Tselikas L., Michiels S., Nikolaev S.I., Scoazec J.Y., Ponce-Aix S., Besse B., Olaussen K.A., Loriot Y, & Friboulet L. (2023). Resistance to Selective FGFR Inhibitors in FGFR-Driven Urothelial Cancer. Cancer Discovery, 13(9), 1998-2011.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!